It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.
This treatment is utilized among a few alternative approaches for patients with terminal pancreatic cancer, specifically those whose standard chemotherapy regimen of gemcitabine has ceased to be effective.